CFMS

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Conformis Inc.

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
CEO
Employees
259
Headquarters

News

Conformis, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:CFMS)
Aug 15, 2022 17:55pm

The following slide deck was published by Conformis, Inc.


Source:Seeking Alpha
Conformis Inc. (CFMS) Worth Considering For The Next Few Weeks
Aug 12, 2022 11:00am

Conformis Inc. (NASDAQ:CFMS) concluded the trading at $0.34 on Thursday, August 11 with a rise of 14.92% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.29 and 5Y monthly beta was reading 1.46 with its price kept floating in the range … Conformis Inc. (CFMS) Worth Considering For The Next Few Weeks Read More »


Source:Stocks Register
Conformis, Inc. (CFMS) CEO Mark Augusti on Q2 2022 Results - Earnings Call Transcript
Aug 09, 2022 15:55pm

Start Time: 08:30 End Time: 08:57 Conformis, Inc. (NASDAQ:NASDAQ:CFMS) Q2 2022 Earnings Conference Call August 09, 2022, 08:30 AM ET Company Participants Mark Augusti - President and CEO…


Source:Seeking Alpha
Recap: Conformis Q2 Earnings
Aug 08, 2022 21:06pm

Conformis (NASDAQ: CFMS ) reported its Q2 earnings results on Monday, August 8, 2022 at 05:05 PM. Here''s what investors need to know about the announcement. Earnings Conformis missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an … Full story available on Benzinga.com


Source:Benzinga
ConforMIS GAAP EPS of -$0.09 misses by $0.01, revenue of $15.3M beats by $0.15M (NASDAQ:CFMS)
Aug 08, 2022 21:03pm

ConforMIS press release (CFMS): Q2 GAAP EPS of -$0.09 misses by $0.01.Revenue of $15.3M (-72.8% Y/Y) beats by $0.15M.Shares +3.3% AH.Outlook: We expect our third quarter product…


Source:Seeking Alpha
Conformis Reports Second Quarter 2022 Financial Results
Aug 08, 2022 20:45pm

BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2022.


Source:GlobeNewswire
ConforMIS Q2 2022 Earnings Preview
Aug 05, 2022 21:35pm

ConforMIS (CFMS) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close.The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is…


Source:Seeking Alpha
Seducing stocks: Conformis, Inc. (NASDAQ:CFMS 3.43%), Seelos Therapeutics, Inc. (NASDAQ:SEEL 3.14%)
Aug 02, 2022 23:41pm

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Seducing stocks: Conformis, Inc. (NASDAQ:CFMS 3.43%), Seelos Therapeutics, Inc. (NASDAQ:SEEL 3.14%) appeared first on Stocks Equity .


Source:Stock Equity
Conformis Shares Jump On Personalized Orthopedic Implants Contract
Aug 02, 2022 13:37pm

Conformis Inc (NASDAQ: CFMS ) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient''s membership of healthcare facilities. The agreement gives increased access to the entire Conformis knee and hip portfolio to Vizient''s membership base, which comprises academic medical centers, pediatric facilities, community hospitals, … Full story available on Benzinga.com


Source:Benzinga
Conformis signs agreement with Vizient for personalized orthopedic implants
Aug 01, 2022 21:10pm

Medical device firm Conformis (CFMS) said it had entered into a multi-year agreement with Vizient to offer its personalized orthopedic implants. (CFMS) is trading 5.9% higher after…


Source:Seeking Alpha
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
Aug 01, 2022 20:30pm

Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions, including its new Image-to-Implant® Platinum Services℠ Program Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions, including its new Image-to-Implant® Platinum Services℠ Program


Source:GlobeNewswire
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Jul 28, 2022 20:30pm

BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in the Canaccord Genuity 42 nd Annual Growth Conference.


Source:GlobeNewswire
Is Now An Ideal Time To Purchase Conformis Inc. (NASDAQ: CFMS) Stock?
Jul 20, 2022 18:00pm

Conformis Inc. (NASDAQ:CFMS) traded at $0.29 at last check on Wednesday, July 20, made an upward move of 2.99% on its previous day’s price. Looking at the stock we see that its previous close was $0.29 and the beta (5Y monthly) reads 1.41 with the day’s price range being $0.2853 – $0.297. In terms of … Is Now An Ideal Time To Purchase Conformis Inc. (NASDAQ: CFMS) Stock? Read More »


Source:Stocks Register
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
Jul 05, 2022 20:30pm

BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the second quarter ended June 30, 2022, after the market closes on Monday, August 8, 2022.


Source:GlobeNewswire
Conformis Inc. (NASDAQ: CFMS): Stock No Longer In Decline?
Jun 21, 2022 14:30pm

The trading price of Conformis Inc. (NASDAQ:CFMS) closed lower on Friday, June 17, closing at $0.28, -3.34% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $0.27 and … Conformis Inc. (NASDAQ: CFMS): Stock No Longer In Decline? Read More »


Source:Stocks Register